Nuclear Pharmacy Market Size, Share & Trends Analysis Report By Type (Diagnostic Nuclear Medicine (SPECT Radiopharmaceuticals, PET Radiopharmaceuticals), Therapeutic Nuclear Medicine (Alpha Emitters, Beta Emitters), Brachytherapy Isotopes. By Application (Diagnostic Applications (SPECT Applications, PET Applications), Therapeutic Applications), By Region, And By Segment Forecasts, 2025-2034

Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global Nuclear Pharmacy Market Snapshot Chapter 4. Global Nuclear Pharmacy Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Drivers 4.3. Challenges 4.4. Trends 4.5. Investment and Funding Analysis of Metaverse Industry 4.6. Industry Analysis – Porter's Five Forces Analysis 4.7. COVID-19 Impact on Metaverse Industry Chapter 5. Market Segmentation 1: By Type Estimates & Trend Analysis 5.1. By Type & Market Share, 2024 & 2034 5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Type: 5.2.1. Diagnostic Nuclear Medicine 5.2.1.1. SPECT Radiopharmaceuticals 5.2.1.1.1. Tc-99m 5.2.1.1.2. I-123 5.2.1.1.3. Tl-201 5.2.1.1.4. Ga-67 5.2.1.1.5. Other SPECT Isotopes 5.2.1.2. PET Radiopharmaceuticals 5.2.1.2.1. F-18 5.2.1.2.2. Rb-82 5.2.1.2.3. Other PET Isotopes 5.2.2. Therapeutic Nuclear Medicine 5.2.2.1. Alpha Emitters 5.2.2.1.1. Ra-223 5.2.2.2. Beta Emitters 5.2.2.2.1. I-131 5.2.2.2.2. Y-90 5.2.2.2.3. Sm-153 5.2.2.2.4. Lu-177 5.2.2.2.5. Re-186 5.2.2.2.6. Other Beta Emitters 5.2.3. Brachytherapy Isotopes 5.2.3.1. I-125 5.2.3.2. Ir-192 5.2.3.3. Pd-103 5.2.3.4. Cs-131 5.2.3.5. Other Brachytherapy Isotopes Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis 6.1. By Type & Market Share, 2024 & 2034 6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Application: 6.2.1. Diagnostic Applications 6.2.1.1. SPECT Applications 6.2.1.1.1. Cardiology 6.2.1.1.2. Bone Scans 6.2.1.1.3. Thyroid Applications 6.2.1.1.4. Pulmonary Scans 6.2.1.1.5. Other SPECT Applications 6.2.1.2. PET Applications 6.2.1.2.1. Oncology 6.2.1.2.2. Cardiology 6.2.1.2.3. Neurology 6.2.1.2.4. Other PET Applications 6.2.2. Therapeutic Applications 6.2.2.1. Thyroid Indications 6.2.2.2. Bone Metastasis 6.2.2.3. Lymphoma 6.2.2.4. Endocrine Tumors 6.2.2.5. Other Indications Chapter 7. Nuclear Pharmacy Market Segmentation 4: Regional Estimates & Trend Analysis 7.1. North America 7.1.1. North America Nuclear Pharmacy Market revenue (US$ Million) estimates and forecasts By Type, 2021-2034 7.1.2. North America Nuclear Pharmacy Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034 7.1.3. North America Nuclear Pharmacy Market revenue (US$ Million) estimates and forecasts by country, 2021-2034 7.1.3.1. U.S. 7.1.3.2. Canada 7.2. Europe 7.2.1. Europe Nuclear Pharmacy Market revenue (US$ Million) by By Type, 2021-2034 7.2.2. Europe Nuclear Pharmacy Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034 7.2.3. Europe Nuclear Pharmacy Market revenue (US$ Million) by country, 2021-2034 7.2.3.1. Germany 7.2.3.2. Poland 7.2.3.3. France 7.2.3.4. Italy 7.2.3.5. Spain 7.2.3.6. UK 7.2.3.7. Rest of Europe 7.3. Asia Pacific 7.3.1. Asia Pacific Nuclear Pharmacy Market revenue (US$ Million) by By Type, 2021-2034 7.3.2. Asia Pacific Nuclear Pharmacy Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034 7.3.3. Asia Pacific Nuclear Pharmacy Market revenue (US$ Million) by country, 2021-2034 7.3.3.1. China 7.3.3.2. India 7.3.3.3. Japan 7.3.3.4. Australia 7.3.3.5. Rest of Asia Pacific 7.4. Latin America 7.4.1. Latin America Nuclear Pharmacy Market revenue (US$ Million) by By Type, 2021-2034 7.4.2. Latin America Nuclear Pharmacy Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034 7.4.3. Latin America Nuclear Pharmacy Market revenue (US$ Million) by country, (US$ Million) 2021-2034 7.4.3.1. Brazil 7.4.3.2. Rest of Latin America 7.5. Middle East & Africa 7.5.1. Middle East & Africa Nuclear Pharmacy Market revenue (US$ Million) by By Type, 2021-2034 7.5.2. Middle East & Africa Nuclear Pharmacy Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034 7.5.3. Middle East & Africa Nuclear Pharmacy Market revenue (US$ Million) by country, (US$ Million) 2021-2034 7.5.3.1. South Africa 7.5.3.2. GCC Countries 7.5.3.3. Rest of MEA Chapter 8. Competitive Landscape 8.1. Major Mergers and Acquisitions/Strategic Alliances 8.2. Company Profiles 8.2.1 GE HealthCare 8.2.2 Cardinal Health 8.2.3 Curium 8.2.4 Bayer AG 8.2.5 Lantheus Holdings, Inc. 8.2.6 Bracco Imaging S.p.A. 8.2.7 PharmaLogic Holdings Corp. 8.2.8 Eczacibasi-Monrol Nuclear Products 8.2.9 NTP Radioisotopes SOC Ltd 8.2.10 Nordion Inc. 8.2.11 Novartis (Advanced Accelerator Application) 8.2.12 NorthStar Medical Radioisotopes 8.2.13 Eckert & Ziegler 8.2.14 Isotope JSC 8.2.15 Siemens Healthineers 8.2.16 Jubilant DraxImage,Inc. 8.2.17 Telix Pharmaceuticals Limited 8.2.18 Mallinckrodt Pharmaceuticals 8.2.19 Bracco 8.2.20 IBA Worldwide 8.2.21 Other Prominent Players